Nephrotoxicity of streptozotocin (NSC-85998).
D007516:Adenoma, Islet Cell / Q000188:drug therapy; D000903:Antibiotics, Antineoplastic / Q000633:toxicity*; D002283:Carcinoma, Bronchogenic / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003110:Colonic Neoplasms / Q000188:drug therapy; D005198:Fanconi Syndrome / Q000139:chemically induced; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced*; D007684:Kidney Tubules / Q000187:drug effects; D009584:Nitrogen / Q000097:blood; D009603:Nitroso Compounds / Q000633:toxicity*; D010018:Osteomalacia / Q000139:chemically induced; D010190:Pancreatic Neoplasms / Q000188:drug therapy; D012004:Rectal Neoplasms / Q000188:drug therapy; D013311:Streptozocin / Q000633:toxicity; D014508:Urea / Q000633:toxicity*; D014511:Uremia / Q000139:chemically induced
D000903:Antibiotics, Antineoplastic; D009603:Nitroso Compounds; D013311:Streptozocin; D014508:Urea; D009584:Nitrogen